BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 90 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $746,834 | +70.6% | 16,600 | +66.1% | 0.00% | +100.0% |
| Q4 2022 | $437,837 | +77.3% | 9,994 | +316.2% | 0.00% | 0.0% |
| Q3 2021 | $247,000 | -78.9% | 2,401 | -77.0% | 0.00% | -80.0% |
| Q4 2020 | $1,173,000 | -68.8% | 10,460 | -83.7% | 0.01% | -82.8% |
| Q1 2020 | $3,760,000 | -20.3% | 64,308 | +9.2% | 0.03% | -12.1% |
| Q4 2019 | $4,719,000 | +158.0% | 58,900 | +136.5% | 0.03% | +106.2% |
| Q3 2019 | $1,829,000 | +553.2% | 24,900 | +741.8% | 0.02% | +433.3% |
| Q2 2019 | $280,000 | +2.9% | 2,958 | -13.0% | 0.00% | 0.0% |
| Q1 2019 | $272,000 | -76.0% | 3,400 | -76.6% | 0.00% | -50.0% |
| Q3 2018 | $1,132,000 | -17.9% | 14,500 | -33.2% | 0.01% | -25.0% |
| Q2 2018 | $1,378,000 | +70.8% | 21,711 | +146.7% | 0.01% | +100.0% |
| Q1 2018 | $807,000 | +85.1% | 8,800 | -19.3% | 0.00% | +33.3% |
| Q1 2017 | $436,000 | +2080.0% | 10,900 | +990.0% | 0.00% | – |
| Q2 2016 | $20,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |